^
BIOMARKER:

BCL2L1 overexpression

i
Other names: BCL2L1, Bcl-X, bcl-xL, bcl-xS, BCL2L, BCLX, PPP1R52, BCL2-like 1
Entrez ID:
Related biomarkers:
BCL2L1 overexpression
Diffuse Large B Cell Lymphoma
rituximab
Resistant: C3 – Early Trials
BCL2L1 overexpression
ALL
venetoclax
Resistant: C3 – Early Trials
BCL2L1 overexpression
Multiple Myeloma
venetoclax
Sensitive: D – Preclinical
BCL2L1 overexpression
Gastric Cancer
APG-1252
Sensitive: D – Preclinical
BCL2L1 overexpression
Mantle Cell Lymphoma
venetoclax
Resistant: D – Preclinical
BCL2L1 overexpression
AML
venetoclax + AZD5991
Sensitive: D – Preclinical
BCL2L1 overexpression
Pancreatic Cancer
ABT 263 + LY2606368
Sensitive: D – Preclinical